Last reviewed · How we verify

Carphenazin (carfenazine)

FDA-approved active Quality 17/100

At a glance

Generic namecarfenazine
Target5-hydroxytryptamine receptor 2A
Therapeutic areaNeuroscience
PhaseFDA-approved

Approved indications

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: